Josef R Patsch

Author PubWeight™ 65.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab 2014 1.47
2 A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 2002 1.35
3 Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir Res 2007 1.14
4 Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. Obesity (Silver Spring) 2009 1.08
5 Endothelial protein C receptor-dependent inhibition of migration of human lymphocytes by protein C involves epidermal growth factor receptor. J Immunol 2006 1.06
6 Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells. FASEB J 2007 1.05
7 The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice. PLoS One 2010 1.04
8 The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism. Circ Res 2010 1.04
9 Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring) 2008 1.03
10 Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 2010 1.00
11 Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis 2007 0.98
12 The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo. Circulation 2004 0.98
13 Monocyte migration: a novel effect and signaling pathways of catestatin. Eur J Pharmacol 2008 0.98
14 Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes. J Clin Endocrinol Metab 2005 0.98
15 Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis. Circulation 2004 0.97
16 Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism. Circ Res 2009 0.95
17 Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis. Kidney Int 2009 0.95
18 Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J Allergy Clin Immunol 2004 0.95
19 Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I. J Mol Med (Berl) 2005 0.94
20 Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet-neutrophil interactions. Thromb Res 2004 0.94
21 Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis. Eur Heart J 2009 0.94
22 Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol Dial Transplant 2007 0.93
23 Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis. Atherosclerosis 2011 0.92
24 Effect of mirtazapine treatment on body composition and metabolism. J Clin Psychiatry 2006 0.92
25 Migration of leukocytes across an endothelium-epithelium bilayer as a model of renal interstitial inflammation. Am J Physiol Cell Physiol 2007 0.92
26 Olanzapine induces insulin resistance: results from a prospective study. J Clin Psychiatry 2003 0.92
27 The thyromimetic T-0681 protects from atherosclerosis. J Lipid Res 2008 0.91
28 Angiopoietin affects neutrophil migration. Microcirculation 2005 0.91
29 Scavenger receptor class B type I polymorphisms and peripheral arterial disease. Metabolism 2007 0.91
30 Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity (Silver Spring) 2007 0.90
31 The influence of two variants in the adenosine triphosphate-binding cassette transporter 1 gene on plasma lipids and carotid atherosclerosis. Metabolism 2008 0.88
32 The resurgence of thyromimetics as lipid-modifying agents. Curr Opin Investig Drugs 2009 0.88
33 Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin. J Inflamm (Lond) 2006 0.88
34 Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes Res 2002 0.87
35 The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndrome. Obesity (Silver Spring) 2008 0.87
36 Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice. FASEB J 2006 0.87
37 Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 2003 0.86
38 Cholesteryl ester transfer protein: gathering momentum as a genetic marker and as drug target. Curr Opin Lipidol 2003 0.86
39 A gel filtration assay to determine glycogen synthase activity. J Chromatogr B Analyt Technol Biomed Life Sci 2005 0.86
40 Mechanisms of neutrophil transmigration across renal proximal tubular HK-2 cells. Cell Physiol Biochem 2006 0.85
41 Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease. Int J Cardiol 2006 0.85
42 Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression. Endocrinology 2008 0.84
43 Cholesteryl ester transfer protein in metabolic syndrome. Obesity (Silver Spring) 2006 0.83
44 Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein. Atherosclerosis 2011 0.83
45 Phospholipid transfer protein augments apoptosis in THP-1-derived macrophages induced by lipolyzed hypertriglyceridemic plasma. Arterioscler Thromb Vasc Biol 2007 0.83
46 [The metabolic syndrome: effects of a pronounced weight loss induced by bariatric surgery]. Wien Klin Wochenschr 2005 0.82
47 A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change? Obesity (Silver Spring) 2008 0.82
48 Resistin impairs basal and insulin-induced glycogen synthesis by different mechanisms. Mol Cell Endocrinol 2006 0.82
49 Analysis of long-chain omega-3 fatty acid content in fish-oil supplements. Wien Klin Wochenschr 2007 0.81
50 CD40-ligand-dependent induction of COX-2 gene expression in endothelial cells by activated platelets: inhibitory effects of atorvastatin. Blood Coagul Fibrinolysis 2005 0.81
51 [Antipsychotic drug-induced changes in metabolism]. Wien Klin Wochenschr 2006 0.80
52 Cholesteryl ester transfer protein in patients with coronary heart disease. Eur J Clin Invest 2010 0.80
53 Effects of weight loss on lipid transfer proteins in morbidly obese women. Lipids 2009 0.80
54 Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels. Eur Cytokine Netw 2010 0.80
55 Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake. Mol Cell Endocrinol 2011 0.79
56 The soluble leptin receptor in olanzapine-induced weight gain: results from a prospective study. Schizophr Res 2005 0.79
57 Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification. Clin Chem Lab Med 2004 0.79
58 The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study. Clin Biochem 2008 0.79
59 Hepatic ENPP1 expression is induced in diabetic rabbits. Mamm Genome 2006 0.78
60 Thrombin affects eosinophil migration via protease-activated receptor-1. Int Arch Allergy Immunol 2004 0.78
61 The K121Q polymorphism of ENPP1 and peripheral arterial disease. Heart Vessels 2008 0.78
62 Neurokinin-1 receptor interacts with PrP(106-126)-induced dendritic cell migration and maturation. J Neuroimmunol 2005 0.77
63 Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein. J Lipid Res 2002 0.77
64 Influence of aspirin on SR-BI expression in human carotid plaques. Atherosclerosis 2009 0.77
65 Differential effects of NO inhibition in renal epithelial and endothelial cells in mono-culture vs. co-culture conditions. Cell Physiol Biochem 2010 0.77
66 A murine model of phosphate nephropathy. Am J Pathol 2011 0.77
67 Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18fluorodeoxyglucose-positron emission tomography. Circulation 2003 0.77
68 Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy. Metabolism 2002 0.77
69 [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)]. Wien Klin Wochenschr 2010 0.77
70 Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study. J Clin Psychiatry 2009 0.77
71 Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits. Atherosclerosis 2012 0.76
72 Images in cardiovascular medicine. Malicious licorice. Circulation 2008 0.76
73 Olanzapine-induced hyperglycemia: role of humoral insulin resistance-inducing factors. J Clin Psychopharmacol 2005 0.76
74 Interferon-alpha suppresses leptin levels: studies in interferon-alpha treated patients with hepatitis C virus infection and murine adipocytes. Eur Cytokine Netw 2002 0.76
75 Effect of weight loss on serum pigment epithelium-derived factor levels. Eur J Clin Invest 2011 0.76
76 Src tyrosine kinase-dependent migratory effects of antithrombin in leukocytes. Exp Cell Res 2005 0.76
77 Expression and function of syndecan-4 in human platelets. Thromb Haemost 2005 0.76
78 Sweet heart block. Circulation 2008 0.75
79 Postprandial, but not postabsorptive low-density lipoproteins increase the expression of intercellular adhesion molecule-1 in human aortic endothelial cells. Atherosclerosis 2005 0.75
80 In vivo application of adenoviral vectors purified by a Taqman Real Time PCR-supported chromatographic protocol. Int J Biol Macromol 2006 0.75
81 Adipocyte fatty acid binding protein during refeeding of female patients with anorexia nervosa. Eur J Nutr 2009 0.75
82 Renal cysts and diabetes due to a heterozygous HNF-1beta gene deletion. Nephrol Dial Transplant 2006 0.75